• Rajasthan

    Cong 99
    BJP 73
    RLM 3
    OTH 24
  • Madhya Pradesh

    Cong 114
    BJP 109
    BSP 2
    OTH 5
  • Chhattisgarh

    Cong 67
    BJP 15
    JCC 7
    OTH 0
  • Telangana

    TRS-AIMIM 95
    TDP-Cong 21
    BJP 1
    OTH 2
  • Mizoram

    MNF 26
    Cong 5
    BJP 1
    OTH 8

* Total Tally Reflects Leads + Wins

Eris Lifesciences shares end flat in debut trade

By: | Published: June 30, 2017 4:49 AM

Shares of pharmaceutical company Eris Lifesciences surrendered early gains and ended flat in its debut trade on Thursday. The stock made its debut on BSE at `612, a 1.49% premium to its issue price of `603.

Eric Lifesciences, Eric Lifesciences latest news, Eric Lifesciences newsEris Lifesciences shares end flat in debut trade (Reuters).

Shares of pharmaceutical company Eris Lifesciences surrendered early gains and ended flat in its debut trade on Thursday. The stock made its debut on BSE at `612, a 1.49% premium to its issue price of `603. It touched its intraday high and low of `627.70 and `592.30, respectively, before closing the day at `601.05, down 0.32% from its issue price. The initial public offering (IPO) of the company was subscribed 3.29 times with investors bidding for 5.24 crore shares against 1.59 crore shares reserved. Qualified institutional buyers had bid for 4.03 crore shares of the 86.17 lakh shares reserved for them. High net-worth individuals (HNIs) bid for 19.37 lakh shares against 43.08 lakh shares reserved for them, retail investors bid for 100,59,816 shares against 28.72 lakh shares reserved for them and employees bid 1.29 lakh shares against 1.5 lakh shares reserved for them. Eris Lifesciences finalised the allotment of 1.29 crore equity shares at `603 per equity share aggregating to `779.43 crore to 21 anchor investors. The pharmaceutical company has priced its IPO between `600 and `603 per equity share. The IPO comprises an offer for sale (OFS) of 2.88 crore equity shares by shareholders.Axis Capital, Citigroup Global Markets India and Credit Suisse Securities are book running lead managers to the issue.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition